Pharmacotherapy
Overview
Pharmacotherapy is a peer-reviewed journal dedicated to advancing the field of pharmacology and therapeutics. It publishes original research, reviews, and case reports on the safe and effective use of medications in the treatment of various diseases. With a focus on evidence-based practice, this journal serves as a valuable resource for healthcare professionals seeking to optimize drug therapy and improve patient outcomes.
Details
Details
Abbr.
Pharmacotherapy
Start
1981
End
Continuing
Frequency
Monthly, 1999-
p-ISSN
0277-0008
e-ISSN
1875-9114
Country
United States
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 2054
126
SJR / Ranks: 4199
943
CiteScore / Ranks: 1714
9.20
JIF / Ranks: 2178
4.1
Recent Articles
1.
Matsuura T, Tawfik A, Ben-Umeh K, Hansten P, Malone D
Pharmacotherapy
. 2025 Mar;
45(3):169-176.
PMID: 40035448
Objective: Hyponatremia is a common electrolyte disorder among older adults that can cause serious adverse effects. The purpose of this study was to assess the risk of hyponatremia with the...
2.
Silva Almodovar A, Donneyong M, Seiber E, Nahata M
Pharmacotherapy
. 2025 Mar;
PMID: 40035429
Introduction: The prevalence of exposure to supratherapeutic doses or contraindicated medications based on renal dosing criteria, also known as potentially inappropriately prescribed medications (PIPM), is currently unknown among patients on...
3.
Hooper L, Liu S, Pai M
Pharmacotherapy
. 2025 Feb;
PMID: 39989027
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are breakthrough medicines for obesity treatment and have rapidly gained widespread clinical application. Although GLP-1RAs are generally not associated with drug-drug interactions (DDIs) via...
4.
Eagan K, Bolch C, Van Dril E, Schumacher C
Pharmacotherapy
. 2025 Feb;
PMID: 39989005
Study Objective: The primary objective of this study was to determine if there was a significant change in potassium levels with sodium-glucose co-transporter-2 (SGLT2) inhibitor therapy in people with type...
5.
Ryan M, Megyeri S, Nuffer W, Trujillo J
Pharmacotherapy
. 2025 Feb;
45(3):177-186.
PMID: 39980227
Osteoarthritis (OA) is the most common form of arthritis, affecting over 500 million people globally. Current treatments are primarily symptom-focused, with no approved therapies to halt disease progression. Glucagon-like peptide-1...
6.
Kow C, Ramachandram D, Hasan S, Thiruchelvam K
Pharmacotherapy
. 2025 Feb;
PMID: 39960170
No abstract available.
7.
8.
Williams V, Gerlach A
Pharmacotherapy
. 2025 Feb;
45(3):161-168.
PMID: 39945448
Introduction: The use of serum creatinine (SCr) for drug dosing has significant limitations and is influenced by many non-kidney factors. Cystatin C (cysC) is an alternative or additional marker of...
9.
10.
Gama Marques J, Finsterer J
Pharmacotherapy
. 2025 Feb;
45(2):145-146.
PMID: 39945397
No abstract available.